Literature DB >> 9238848

Nongenomic actions of steroids on gonadotropin release.

J P Wiebe1.   

Abstract

The release of gonadotropins is effected by GnRH and regulated by steroids. The classical mechanism of steroid hormone action, which implies the binding of hormone receptor complexes to regulatory elements of nuclear genes, is derived largely from the well-studied and familiar steroids such as progesterone, testosterone, and estradiol. Their effects on gonadotropin release generally have been examined following hours or days of exposure and therefore cannot account for the rapid effects of steroids on gonadotropin release. Moreover, tissues such as gonad, pituitary, and hypothalamus can produce a variety of hormonally active steroids in addition to these well-studied, traditional ones. The recently discovered allylic steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), is readily interconverted from/to progesterone and is found at appreciable levels in serum, gonads, pituitary, hypothalamus, and other tissues. 3 alpha HP has provided the "missing link" in the progesterone biosynthetic/ metabolic pathways, allowing cyclical 4-pregnene and 5 alpha-pregnane pathways to be described for steroidogenic tissues. Among the functions ascribed to 3 alpha HP is the ability to selectively and rapidly (within seconds or minutes) suppress GnRH-provoked FSH release. In vitro studies using pituitary gonadotropes in culture and in perifusion paradigms suggest that suppression of FSH release by 3 alpha HP occurs as a result of nongenomic mechanisms of action. These mechanisms are discussed and include interaction at the level of receptors in the gonadotrope membrane and the cell-signaling pathway involving protein kinase C, phospholipase C, or IP3-induced Ca2+ mobilization and Ca2+ channels. This may be the first evidence of a gonadal steroid regulating gonadotropin release by nongenomic mechanisms of action. In order to understand the critical role of steroids in the rapid regulation of secretory (and bence, circulating) levels of gonadotropins, other gonadal steroids will need to be examined for their nongenomic action on gonadotropes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9238848

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  9 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  Rapid actions of 17beta-oestradiol on a subset of lactotrophs in the rat pituitary.

Authors:  H C Christian; J F Morris
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

3.  Ovarian influence on gonadotropin and prolactin release in mated rabbits.

Authors:  C Y Pau; K Y Pau; M Berria; H G Spies
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

4.  Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein.

Authors:  Marissa I Boulware; Jason P Weick; Bryan R Becklund; Sidney P Kuo; Rachel D Groth; Paul G Mermelstein
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

Review 5.  Membrane estrogen receptors activate metabotropic glutamate receptors to influence nervous system physiology.

Authors:  Marissa I Boulware; Paul G Mermelstein
Journal:  Steroids       Date:  2008-11-25       Impact factor: 2.668

6.  The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor.

Authors:  D C Skinner; N P Evans; B Delaleu; R L Goodman; P Bouchard; A Caraty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Acute, nongenomic actions of the neuroactive gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), on FSH release in perifused rat anterior pituitary cells.

Authors:  C A Beck; M Wolfe; L D Murphy; J P Wiebe
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

Review 8.  Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors.

Authors:  P G Mermelstein
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

9.  Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma.

Authors:  Michael J Lewis; John P Wiebe; J Godfrey Heathcote
Journal:  BMC Cancer       Date:  2004-06-22       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.